https://vaccigen.ca/ 2026-02-07T10:51:09+00:00 1.00 https://vaccigen.ca/about-ocugen/ 2026-02-07T10:51:09+00:00 0.80 https://vaccigen.ca/about-vaccigen/ 2026-02-07T10:51:09+00:00 0.80 https://vaccigen.ca/scientific-platforms/ 2026-02-07T10:51:09+00:00 0.80 https://vaccigen.ca/patients/ 2026-02-07T10:51:09+00:00 0.80 https://vaccigen.ca/therapeutic-areas/ 2026-02-07T10:51:09+00:00 0.80 https://vaccigen.ca/contactus/ 2026-02-07T10:51:09+00:00 0.80 https://vaccigen.ca/ocugens-covid-19-vaccine-co-development-partner-bharat-biotech-shares-phase-3-results-demonstrating-77-8-protection-against-overall-disease/ 2026-02-07T10:51:09+00:00 0.80 https://vaccigen.ca/ocugen-inc-parent-company-of-vaccigen-ltd-signs-letter/ 2026-02-07T10:51:09+00:00 0.80 https://vaccigen.ca/b-1-617-variant-which-is-effectively-neutralized-by-covaxin-rapidly-spreading-in-17-countries-including-us/ 2026-02-07T10:51:09+00:00 0.80 https://vaccigen.ca/vaccine-overview/ 2026-02-07T10:51:09+00:00 0.80 https://vaccigen.ca/vaccigens-parent-company-ocugen-announces-positive-top-line-data-for-covid-19-vaccine-candidate-covaxin-bbv152-in-phase-2-3-immuno-bridging-and-broadening-study-both-co-primary-en/ 2026-02-07T10:51:09+00:00 0.80 https://vaccigen.ca/vaccigens-parent-company-ocugen-announces-fda-approval-for-enrollment-of-pediatric-patients-in-ongoing-ocu400-phase-1-2-clinical-trial-for-the-treatment-of-retinitis-pigmentosa-rp-and-leber-conge/ 2026-02-07T10:51:09+00:00 0.80 https://vaccigen.ca/ocugen-announces-positive-preliminary-safety-and-efficacy-results-from-the-phase-1-2-trial-of-ocu400-a-modifier-gene-thraphy-product-candidate-for-the-treatment-of-retinitis-pigmentosa-and-leber-con/ 2026-02-07T10:51:09+00:00 0.80 https://vaccigen.ca/ocugen-announes-ocu410st-receives-orphan-drug-designationfor-treatment-of-abca4-associated-retinopathies/ 2026-02-07T10:51:09+00:00 0.80 https://vaccigen.ca/vaccines/ 2026-02-07T10:51:09+00:00 0.64 https://vaccigen.ca/cell-therapies/ 2026-02-07T10:51:09+00:00 0.64 https://vaccigen.ca/gene-therapies/ 2026-02-07T10:51:09+00:00 0.64 https://vaccigen.ca/biologicals/ 2026-02-07T10:51:09+00:00 0.64 https://vaccigen.ca/covaxin-bbv152/ 2026-02-07T10:51:09+00:00 0.64 https://vaccigen.ca/ocu400/ 2026-02-07T10:51:09+00:00 0.64